Gene Methylation in Ductal Lavage Fluid of BRCA Mutation Carriers
Author Information
Author(s): Imogen Locke, Zsofia Kote-Jarai, Mary Jo Fackler, Elizabeth Bancroft, Peter Osin, Ashutosh Nerurkar, Louise Izatt, Gabriella Pichert, Gerald Gui, Rosalind Eeles
Primary Institution: Institute of Cancer Research
Hypothesis
Do healthy BRCA mutation carriers show increased gene promoter hypermethylation in ductal lavage fluid compared to controls?
Conclusion
The study found significant levels of aberrant methylation in the ductal lavage fluid of healthy BRCA mutation carriers compared to controls.
Supporting Evidence
- 42.1% of BRCA mutation carriers had at least one hypermethylated gene.
- No hypermethylation was found in controls.
- Methylation analysis may serve as a surrogate marker for breast cancer risk.
Takeaway
The study looked at women with BRCA gene mutations and found that some had changes in their breast fluid that might indicate a higher risk of breast cancer.
Methodology
Methylation-specific PCR was used to analyze free DNA extracted from ductal lavage fluid.
Limitations
The small number of controls limited the ability to reach statistical significance.
Participant Demographics
24 women, including 19 BRCA mutation carriers (7 BRCA1 and 12 BRCA2) and 5 controls.
Statistical Information
P-Value
0.13
Statistical Significance
p = 0.13
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website